Diagnosis and management of precocious puberty

Mark D Wheeler, D. M. Styne

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The onset of pubertal development before the age of 8 years in girls and 9 years in boys constitutes precocious puberty. Central precocious puberty results from premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty results from extrapituitary gonadotropin secretion or secretion of sex steroids independent of pituitary gonadotropins. Long-acting GnRH agonists afford effective, selective, and reversible therapy of cental precocious puberty without significant toxicity. GnRH agonists are not effective in managing the premature sexual maturation associated with peripheral precocious puberty, but a number of other agents have been used with some success.

Original languageEnglish (US)
Pages (from-to)1255-1271
Number of pages17
JournalPediatric Clinics of North America
Volume37
Issue number6
StatePublished - 1990
Externally publishedYes

Fingerprint

Precocious Puberty
Gonadotropin-Releasing Hormone
Pituitary Gonadotropins
Sexual Maturation
Gonadotropins
Steroids
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Diagnosis and management of precocious puberty. / Wheeler, Mark D; Styne, D. M.

In: Pediatric Clinics of North America, Vol. 37, No. 6, 1990, p. 1255-1271.

Research output: Contribution to journalArticle

@article{7d5940d5e47447aea1b855216aafcd1c,
title = "Diagnosis and management of precocious puberty",
abstract = "The onset of pubertal development before the age of 8 years in girls and 9 years in boys constitutes precocious puberty. Central precocious puberty results from premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty results from extrapituitary gonadotropin secretion or secretion of sex steroids independent of pituitary gonadotropins. Long-acting GnRH agonists afford effective, selective, and reversible therapy of cental precocious puberty without significant toxicity. GnRH agonists are not effective in managing the premature sexual maturation associated with peripheral precocious puberty, but a number of other agents have been used with some success.",
author = "Wheeler, {Mark D} and Styne, {D. M.}",
year = "1990",
language = "English (US)",
volume = "37",
pages = "1255--1271",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Diagnosis and management of precocious puberty

AU - Wheeler, Mark D

AU - Styne, D. M.

PY - 1990

Y1 - 1990

N2 - The onset of pubertal development before the age of 8 years in girls and 9 years in boys constitutes precocious puberty. Central precocious puberty results from premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty results from extrapituitary gonadotropin secretion or secretion of sex steroids independent of pituitary gonadotropins. Long-acting GnRH agonists afford effective, selective, and reversible therapy of cental precocious puberty without significant toxicity. GnRH agonists are not effective in managing the premature sexual maturation associated with peripheral precocious puberty, but a number of other agents have been used with some success.

AB - The onset of pubertal development before the age of 8 years in girls and 9 years in boys constitutes precocious puberty. Central precocious puberty results from premature activation of the hypothalamic-pituitary-gonadal axis, and peripheral precocious puberty results from extrapituitary gonadotropin secretion or secretion of sex steroids independent of pituitary gonadotropins. Long-acting GnRH agonists afford effective, selective, and reversible therapy of cental precocious puberty without significant toxicity. GnRH agonists are not effective in managing the premature sexual maturation associated with peripheral precocious puberty, but a number of other agents have been used with some success.

UR - http://www.scopus.com/inward/record.url?scp=0025670309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025670309&partnerID=8YFLogxK

M3 - Article

C2 - 2147987

AN - SCOPUS:0025670309

VL - 37

SP - 1255

EP - 1271

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 6

ER -